Duloxetine (Cymbalta): A new SNRI for depression

Medical Letter on Drugs and Therapeutics

Volumn 46, Issue 1193, 2004, Pages 81-83

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A2; CYTOCHROME P450 2D6; DULOXETINE; SEROTONIN UPTAKE INHIBITOR; THIOPHENE DERIVATIVE;

ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEPRESSION; DRUG INTERACTION; HALF LIFE TIME; HUMAN; LIVER; METABOLISM; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP2D6; DEPRESSION; DRUG INTERACTIONS; HALF-LIFE; HUMANS; LIVER; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS; THIOPHENES;

EID: 6944230971     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (7)

1. Is Effexor more effective for depression than an SSRI? Med Lett Drugs Ther 2004; 46:15.
2. MJ Detke et al. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. J Clin Psychiatry 2002; 63:308.
3. MJ Detke et al. Duloxetine 60 mg once daily versus placebo in the acute treatment of major depression. J Psychiatr Res 2002; 36:383.
4. DJ Goldstein et al. Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine. J Clin Psychopharmacol 2004; 24:389.
5. DJ Goldstein et al. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial. J Clin Psychiatry 2002; 63:225.
6. MJ Detke et al. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Eur Neuropsychopharmacol 2004, in press.
7. M Fava et al. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates? J Clin Psychiatry 2004; 65:521.